$COCHSep 2, 2026, 12:30 PMAI processed
Envoy Medical (COCH) to present at H.C. Wainwright conference on Sept. 15
AI Summary
Envoy Medical (COCH) said CEO Brent Lucas will present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 15 at 2:00 PM ET; the presentation will be webcast and available on demand for 90 days. The company highlights its innovation pipeline in the release — including the investigational Acclaim fully implanted cochlear implant (FDA Breakthrough Device) and the commercial Esteem implant — so the session is a likely venue for pipeline, clinical or regulatory updates.
Positives
- CEO Brent Lucas scheduled to present at a major investor conference (Sept. 15, 2:00 PM ET)
- Presentation will be webcast with on-demand replay available for 90 days
- Company callout of pipeline assets, including investigational Acclaim CI (FDA Breakthrough) and commercial Esteem
Negatives
- Acclaim cochlear implant remains an investigational device (not approved)
- Press release does not announce any new clinical data or regulatory decisions
- Forward-looking statements underline uncertainty on timing/results of regulatory approvals and trials